drugset / Trial / NCT07475520
Lidocaine IV Injection With Different Doses for Patients With Neuropathic Pain After Mastectomy
RandomizedParallel-groupDouble-blindPrevention
Summary
cancer has become the most common malignancy affecting women worldwide, and its incidence is increasing annually. According to the Global Cancer Observatory (GLOBOCAN) 2020 published by the International Agency for Research on Cancer of the World Health Organization, female breast cancer is the cancer with the highest number of new cases worldwide significant number of patients experiencing moderate to severe acute pain (30-50%) and developing chronic post-surgical pain (CPSP) (25-68%)
Timeline
- Start
- 2022-07-25
- Primary completion
- 2025-08-25
- Completion
- 2025-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Lidocaine | Other / unclassified | 6 mg/kg | Intravenous |
Indications
No indication recorded.